{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:04:16Z","timestamp":1760043856390},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.2967\/jnumed.115.160986","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T02:49:08Z","timestamp":1440730148000},"page":"1793-1799","source":"Crossref","is-referenced-by-count":11,"title":["Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats"],"prefix":"10.2967","volume":"56","author":[{"given":"Tal","family":"Burt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kihak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huali","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita T.","family":"Layton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas H.","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennett B.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cohen-Wolkowiez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shein-Chung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Noveck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"key":"2021051712081738000_56.11.1793.1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e31816b9027"},{"key":"2021051712081738000_56.11.1793.2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.295"},{"key":"2021051712081738000_56.11.1793.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3405"},{"key":"2021051712081738000_56.11.1793.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3078"},{"key":"2021051712081738000_56.11.1793.5","unstructured":"Innovation or stagnation: challenge and opportunity on the critical path to new medical products. Food and Drug Administration website. http:\/\/www.fda.gov\/ScienceResearch\/SpecialTopics\/CriticalPathInitiative\/CriticalPathOpportunitiesReports\/ucm077262.htm. Accessed September 11, 2015."},{"key":"2021051712081738000_56.11.1793.6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2961"},{"key":"2021051712081738000_56.11.1793.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3681"},{"key":"2021051712081738000_56.11.1793.8","doi-asserted-by":"crossref","unstructured":"Coller BS Califf RM . Traversing the Valley of Death: a guide to assessing prospects for translational success. Sci Transl Med. 2009;1:10cm9.","DOI":"10.1126\/scitranslmed.3000265"},{"key":"2021051712081738000_56.11.1793.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001489"},{"key":"2021051712081738000_56.11.1793.10","unstructured":"Rowland M . Microdosing and the 3Rs. National Library of Australia website. http:\/\/trove.nla.gov.au\/version\/166532644. 2006. Accessed September 11, 2015."},{"key":"2021051712081738000_56.11.1793.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000245"},{"key":"2021051712081738000_56.11.1793.12","unstructured":"International Conference on Harmonization. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2). In: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Geneva, Switzerland: ICH Secretariat; 2009:8\u201316."},{"key":"2021051712081738000_56.11.1793.13","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.786042"},{"key":"2021051712081738000_56.11.1793.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0643-x"},{"key":"2021051712081738000_56.11.1793.15","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1037"},{"key":"2021051712081738000_56.11.1793.16","unstructured":"Guidance for industry, investigators, and reviewers exploratory IND studies. Food and Drug Administration website. www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm078933.pdf. Accessed September 11, 2015."},{"key":"2021051712081738000_56.11.1793.17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002747"},{"key":"2021051712081738000_56.11.1793.18","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006299092"},{"key":"2021051712081738000_56.11.1793.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03509-9"},{"key":"2021051712081738000_56.11.1793.20","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-12-RG-044"},{"key":"2021051712081738000_56.11.1793.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2008.00650.x"},{"key":"2021051712081738000_56.11.1793.22","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-008-0165-0"},{"key":"2021051712081738000_56.11.1793.23","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/50\/8\/014"},{"key":"2021051712081738000_56.11.1793.24","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.213.2.r99nv37521"},{"key":"2021051712081738000_56.11.1793.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnene.2013.00013","article-title":"FDG-PET imaging in mild traumatic brain injury: a critical review","volume":"5","author":"Byrnes","year":"2014","journal-title":"Front Neuroenergetics."},{"key":"2021051712081738000_56.11.1793.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.038182"},{"key":"2021051712081738000_56.11.1793.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.12.020"},{"key":"2021051712081738000_56.11.1793.28","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.217"},{"key":"2021051712081738000_56.11.1793.29","doi-asserted-by":"publisher","DOI":"10.2165\/11597070-000000000-00000"},{"key":"2021051712081738000_56.11.1793.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.09.011"},{"key":"2021051712081738000_56.11.1793.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.09.010"},{"key":"2021051712081738000_56.11.1793.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2011.02.004"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.115.160986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:03:57Z","timestamp":1621281837000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.115.160986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,2]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.2967\/jnumed.115.160986"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.115.160986","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}